(NYSEMKT: XTNT) Xtant Medical Holdings's forecast annual revenue growth rate of -10% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.78%.
Xtant Medical Holdings's revenue in 2026 is $133,927,000.On average, 5 Wall Street analysts forecast XTNT's revenue for 2026 to be $13,819,134,532, with the lowest XTNT revenue forecast at $13,105,626,815, and the highest XTNT revenue forecast at $14,369,602,793. On average, 5 Wall Street analysts forecast XTNT's revenue for 2027 to be $15,144,180,271, with the lowest XTNT revenue forecast at $14,275,757,059, and the highest XTNT revenue forecast at $16,016,805,531.
In 2028, XTNT is forecast to generate $16,619,099,049 in revenue, with the lowest revenue forecast at $15,291,251,944 and the highest revenue forecast at $17,899,322,945.